Article8 Oct 2025The role of Epithelial Barrier Components in AD, insights and implicationsLearn more
Article2 Oct 2025Long-term Safety and Efficacy of Avalglucosidase Alfa IN Patients with Late-Onset Pompe Disease (NEO-EXT) Learn more
Article2 Oct 2025Safety and efficacy of Avalglucosidase Alfa versus Alglucosidase Alfa in patints with Late-Onset Pompe Disease (COMET): a phase 3, randomized, multicentral study results Learn more
Article26 Sep 2025Chronic Spontaneous Urticaria is an Immune-Mediated Inflammatory Skin DiseaseLearn more